Journal of Brain And Spinal Cancer

Journal of Brain And Spinal Cancer

Journal of Brain And Spinal Cancer – About

Open Access & Peer-Reviewed

Submit Manuscript

Journal of Brain and Spinal Cancer

Advancing the molecular and mechanistic understanding of central nervous system malignancies through rigorous peer-reviewed pathophysiology research

Decoding the Pathophysiology of CNS Tumors

The Journal of Brain and Spinal Cancer (JBSC) (ISSN 2576-182X) is a peer-reviewed, open-access publication dedicated to advancing the pathophysiological understanding of brain and spinal cord malignancies. We focus on the molecular mechanisms, cellular pathways, and disease models that illuminate how these cancers develop, progress, and resist therapeutic intervention.

JBSC serves as a critical platform for researchers investigating the biological foundations of gliomas, meningiomas, medulloblastomas, ependymomas, and metastatic CNS lesions. Our scope encompasses genetic drivers, epigenetic modifications, tumor microenvironment interactions, metabolic reprogramming, and biomarker discovery - all essential for translating mechanistic insights into future therapeutic strategies.

Research Focus: Pathophysiology at the Molecular Level

Core Mechanistic Domains

JBSC prioritizes research that clarifies how CNS cancers work at the molecular and cellular level, not how they are treated clinically. Our editorial scope encompasses:

  • Tumor Initiation Mechanisms: Genetic mutations, chromosomal aberrations, oncogene activation, tumor suppressor loss
  • Cellular Signaling Pathways: RTK/RAS/PI3K, p53, mTOR, MAPK, Wnt/β-catenin, Hedgehog signaling
  • Epigenetic Dysregulation: DNA methylation patterns, histone modifications, chromatin remodeling, non-coding RNA regulation
  • Tumor Microenvironment: Glia-tumor interactions, immune cell infiltration, angiogenesis, extracellular matrix remodeling

Experimental & Translational Models

We publish studies utilizing diverse experimental systems that model CNS cancer pathophysiology:

  • In Vitro Models: Primary cell cultures, organoid systems, 3D tumor spheroids, co-culture platforms
  • Animal Models: Genetically engineered mouse models (GEMMs), xenograft models, orthotopic implantation, PDX models
  • Ex Vivo Systems: Tumor slice cultures, precision-cut tissue sections, patient-derived explants
  • Computational Models: Systems biology approaches, network analysis, mechanistic simulations

Scope Clarity: JBSC focuses exclusively on disease mechanisms and pathophysiology. We also publish clinical management protocols, treatment guidelines, patient outcome studies, or therapy efficacy trials.

Key Research Areas

Molecular Genetics

IDH mutations, MGMT promoter methylation, 1p/19q codeletion, TERT promoter alterations, EGFR amplification, TP53 mutations

Cell Cycle Dysregulation

CDK pathway alterations, checkpoint dysfunction, mitotic catastrophe, senescence bypass, replication stress responses

Metabolic Reprogramming

Warburg effect, glutamine addiction, lipid metabolism alterations, mitochondrial dysfunction, metabolite profiling

Invasion & Migration

Matrix metalloproteinases, cell adhesion molecules, cytoskeletal dynamics, epithelial-mesenchymal transition, perivascular invasion

Angiogenesis Pathways

VEGF signaling, hypoxia-inducible factors, endothelial cell recruitment, vascular mimicry, pericyte interactions

Biomarker Discovery

Circulating tumor DNA, extracellular vesicles, protein signatures, metabolomic markers, radiogenomic correlations

Stem Cell Biology

Cancer stem cell markers, self-renewal mechanisms, differentiation blockade, niche interactions, hierarchical organization

Immune Evasion

Immune checkpoint expression, myeloid cell recruitment, T cell exclusion, antigen presentation defects, immunosuppressive factors

DNA Damage Response

Repair pathway deficiencies, genomic instability, replication fork dynamics, telomere maintenance, mutagenesis mechanisms

Rigorous Peer Review for Mechanistic Research

All manuscripts undergo comprehensive evaluation by experts in molecular oncology, neurobiology, and pathophysiology. Our review process emphasizes:

  • Mechanistic Depth: Reviewers assess whether findings advance understanding of disease biology at the molecular or cellular level
  • Experimental Rigor: Evaluation of model systems, controls, replication, statistical approaches, and reproducibility
  • Novelty Assessment: Verification that work contributes new mechanistic insights rather than confirmatory observations
  • Data Quality: Scrutiny of methodology, data presentation, and interpretation to ensure scientific validity
  • Scope Alignment: Confirmation that research focuses on pathophysiology rather than clinical practice or patient management
21 days Time to First Decision
59% Acceptance Rate
90+ Countries Represented
100% Open Access
Publication Types

Original Research Articles

Original investigations presenting novel mechanistic findings in CNS cancer pathophysiology. Must include hypothesis-driven experimental design, appropriate controls, statistical validation, and clear demonstration of molecular or cellular insights.

Primary Research Articles

Original studies reporting new empirical findings on brain and spinal cancer mechanisms, with robust experimental design and data analysis.

Mechanistic Reviews

Comprehensive syntheses of current knowledge regarding specific pathophysiological processes in brain and spinal cancers. Must integrate molecular, cellular, and systems-level perspectives.

Systematic Reviews & Meta-Analyses

Critical assessments of existing literature using systematic methods to identify, select, and synthesize relevant research on CNS tumor mechanisms.

Review Articles & Literature Reviews

Authoritative overviews of established areas of CNS cancer research, summarizing current understanding and identifying key knowledge gaps.

Methods & Protocols

Detailed descriptions of experimental procedures and methodological workflows for studying CNS tumor biology.

Methodological Innovations

Papers describing new techniques, models, or analytical approaches for studying CNS tumor biology. Should provide validation data and demonstrate advantages over existing methods.

Biomarker Studies

Research identifying and validating molecular markers of disease state, progression, or biological behavior. Should include mechanistic rationale and experimental verification.

Short Communications

Concise reports of significant preliminary findings that warrant rapid dissemination.

Rapid Communications

Urgent publication of time-sensitive discoveries with high impact potential in CNS cancer research.

Data Notes

Publications describing datasets generated from CNS cancer research, focusing on data quality, availability, and reuse potential.

Technical Notes

Reports on technical improvements, optimizations, or troubleshooting in experimental methods related to brain and spinal cancer studies.

Clinical Case Reports

Detailed descriptions of individual patient cases that reveal novel pathophysiological insights into CNS malignancies.

Clinical Trial Reports

Reports of clinical trials with emphasis on mechanistic endpoints, biomarker correlations, and biological insights gained.

Perspectives

Forward-looking articles discussing emerging trends, challenges, and future directions in CNS cancer research.

Opinion Pieces

Authoritative viewpoints on current issues, controversies, or developments in the field of brain and spinal cancer.

Commentaries

Short articles providing expert analysis and context for recently published research or current topics in the field.

Letters to the Editor

Brief communications commenting on previously published articles or presenting timely observations relevant to the journal's scope.

Editorials

Articles written by editorial board members on topics of special importance or interest to the CNS cancer research community.

Mini-Reviews

Concise, focused reviews on specific topics within brain and spinal cancer pathophysiology.

Book Reviews

Critical evaluations of recently published books relevant to neuro-oncology, cancer biology, or CNS pathophysiology.

Conference Proceedings

Selected papers from scientific conferences focused on brain and spinal cancer research, curated to maintain high standards.

Theses

Summarized versions of outstanding doctoral dissertations that make significant contributions to CNS cancer mechanistic understanding.

Editorial Leadership

JBSC is guided by an international editorial board comprising molecular oncologists, neuroscientists, geneticists, and pathophysiology specialists. Our editors are committed to maintaining rigorous scientific standards while ensuring timely publication of high-quality mechanistic research.

Editorial Board

Expert reviewers from leading research institutions worldwide evaluate manuscripts for mechanistic significance, experimental rigor, and contribution to CNS cancer biology understanding.

Institutional Partnerships

Collaborative relationships with Tata Memorial Hospital, Sapienza University of Rome, University of Milano Bicocca, and other research centers ensure global perspectives in peer review.

Author Benefits
  • Rapid Publication: Streamlined editorial workflow with decisions typically within 21 days and acceptance to publication in 5 days
  • Global Visibility: Indexed in Google Scholar and specialized databases ensuring broad discoverability
  • Open Access: Creative Commons licensing enables unrestricted sharing and citation
  • No Article Length Restrictions: Comprehensive data presentation without arbitrary page limits
  • Supplementary Materials: Support for extensive supplementary data, videos, and protocols
  • Expert Editorial Support: Guidance throughout submission and revision processes

Submit Your Pathophysiology Research

Join the global community of researchers advancing mechanistic understanding of brain and spinal cancer. JBSC welcomes submissions that illuminate the molecular foundations of CNS malignancies. With a submission-to-publication timeline of just 45 days on average, we ensure rapid dissemination of your findings.

Contact Information: For inquiries regarding scope, submission requirements, or editorial policies, contact the JBSC editorial office at [email protected]. We respond to all queries within 48 hours.